UNEXPLAINED MOVE · FRI OCT 23 2026

Why TNGX rose 19.3% on Oct 23 2026: clinical trial results

TNGX+19.3%on Fri Oct 23 2026

Tango Therapeutics, Inc. was up 19.3% on the day at $33.31, ranked #1 on 28.8× its usual five-minute volume, when TapeRank recorded this unexplained move at 06:34 ET during the pre-market session.

THE DAY ON THE LIST · 1 EVENT

  1. 06:34 ET
    UNEXPLAINED MOVE · PRE-MARKET

    $33.31 · ▲ 19.3% ON THE DAY · 28.8× 5M RVOL · RANK #1

    JUSTIFIEDCONFIDENCE5/5

    TNGX is up 8.0% pre-market, with accelerating volume and a 2.48% five-minute gain. The move is explained by strong Phase 1/2 combination data showing an 82% response rate and an 88% nine-month PFS rate in pancreatic cancer patients.

    WHYAn 8% move is proportionate to a potentially material oncology-data catalyst, though the evidence remains early-stage and based on 22 evaluable patients.
    ANALYZED 06:37 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNA
    THE ROW AND SESSION LEVELS AT 06:34 ET
    LAST33.31
    DAY▲ 19.3%
    5 MIN▲ 16.22%
    5M RVOL28.8×
    5M $VOL$477K
    FLOAT*168.6M
    RANK#1
    SESSIONPRE-MARKET
    VWAP29.27
    HOD30.50
    LOD27.50
    OR HIGH—
    OR LOW—
    PREV CLOSE27.93
    PM HIGH30.50
    PM LOW27.50
    GAP▲ 9.20% (indicated)

    * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE

    — MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO

THE SESSION

  • 09:30 ETOpened at $25.54, -8.6% on the previous close of $27.93
  • 09:30 ETRegular-session high, $25.94
  • 10:39 ETRegular-session low, $22.68
  • 15:59 ETLast trade of the regular session, $23.33, -16.5% on the previous close of $27.93
  • Volume: 14.6M shares in regular hours, 687K before the open

TNGX opened at $25.54 after an early premarket surge that TapeRank initially marked unexplained, reaching $33.31 at 06:34 ET. TapeRank later read the move as justified by strong Phase 1/2 combination data, including an 82% response rate and an 88% nine-month PFS rate in pancreatic cancer patients, while noting the results were early-stage and based on 22 evaluable patients. The stock then reversed during regular trading, reaching a $22.68 low at 10:39 ET before recovering to $23.33 at the close, down 16.5% from the previous close; there were no halts.

WRITTEN FRI OCT 23 2026 16:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE

FILINGS AND NEWS · 24H BEFORE THE MOVE

No SEC filings or wire news in the 24 hours before this was recorded. A move on news that never reached the wire shows nothing here, which is what UNEXPLAINED means.

On the tape right now

WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY

01
ECGSURGING 0:05
79.71
▼ 29.3%
▼ 1.41%
41.0×
FAD
$6.2M
51.1M*
STRETCHED
02
CAVASURGING 0:00
64.78
▲ 7.4%
▲ 1.30%
9.3×
ORBHODVWH
$11.6M
116.8M*
UNEXPLAINED
03
URGNSURGING 0:00
29.16
▼ 15.2%
▼ 1.29%
15.6×
FAD
$1.4M
48.9M*
JUSTIFIED
04
MPTISURGING 0:00
64.15
▼ 1.5%
▲ 0.96%
23.8×
VWH
$637K
4.3M*
UNEXPLAINED
05
LSPDSURGING 0:00
11.52
▲ 4.9%
▼ 1.24%
16.5×
ORB
$426K
133.3M*
UNEXPLAINED
06
CRCTSURGING 0:00
8.90
▲ 49.2%
▼ 0.72%
15.1×
GAPORBVWHEXT
$395K
54.7M*
STRETCHED
07
BROSSURGING 0:00
43.97
▲ 0.9%
▼ 0.91%
4.0×
FAD
$4.3M
137.9M*
UNEXPLAINED
08
LMRICOOLING 1:35
12.85
▲ 14.5%
▲ 1.06%
132×
ORBHODVWH
$1.7M
—
UNEXPLAINED
Open the full list